Catabolic factors in cancer cachexia

In Vivo

Volumn 10, Issue 2, 1996, Pages 131-136

  Tisdale, M J ^a   McDevitt, T M ^a   Todorov, P T ^a   Cariuk, P ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Cachexia; Cancer; Catabolic factors

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CACHEXIA; CANCER TRANSPLANTATION; CATABOLISM; COLON ADENOCARCINOMA; EXPERIMENTAL NEOPLASM; IMMUNOBLOTTING; ION EXCHANGE CHROMATOGRAPHY; MOUSE; NONHUMAN; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 0029975419     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Beck SA and Tisdale MJ:Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res 47: 5919-5923, 1987.
2. Smith KL and Tisdale MJ: Mechanism of protein degradation in cancer cachexia. Br J Cancer 68: 314-318, 1993.
3. Beck SA, Mulligan HD and Tisdale MJ: Lipolytic factors associated with murine and human cancer cachexia. J Natl Cancer Inst 82: 1922-1926, 1990.
4. McDevitt TM, Todorov PT, Beck SA, Khan SH and Tisdale MJ: Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans. Cancer Res 55: 1458-1463, 1995.
5. Wieland O: Glycerol UV Method. In Methods Enzymatic Analysis (ed Bergmeyer HU) pp 1404-1409, Academic Press, London, 1974.
6. Kitada S, Hays EF and Mead JF: Characterization of a lipid mobilizing factor from tumors. Prog Lipid Res 20: 823-826, 1981.
7. Kitada S, Hays EF, Mead JF and Zabin I: Lipolysis induction in adipocytes by a protein from tumor cells. J Cell Biochem 20: 409-416, 1982.
8. Masuno H, Yamaskaki N and Okuda H: Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180. Cancer Res 41: 284-288, 1981.
9. Masuno H, Yoshimura H, Ogawa N and Okuda H: Isolation of a lipolytic factor (toxohormone-L) from ascites fluid of patients with hepatoma and its effect on feeding behaviour. Eur J Cancer Clin Oncol 20: 1177-1185, 1992.
10. Taylor DD, Gercel-Taylor C, Jenio LG and Devereux DF: Identification of a human tumor-derived lipolysis-promoting factor. Cancer Res 52: 829-834, 1992.
11. Double JA and Bibby MC: Therapeutic index: A vital component in selection of anticancer agents for clinical trial. J Natl Cancer Inst 81: 988-994, 1989.
12. Tisdale MJ, Brennan RA and Fearon KC: Reduction of weight loss and tumour size in a cachexia model by a high fat diet. Br J Cancer 56: 39-43, 1987.
13. Hudson EA, Beck SA and Tisdale MJ: Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal by linoleic acid. Biochem Pharm 45: 2189-2194, 1993.
14. Hyltander A, Korner U and Ludholm KG: Evaluation of mechanisms behind elevated energy expenditure in cancer patients with solid tumours. Eur J Clin Invest 23: 46-52, 1993.
15. Warnold I, Lundholm K and Schersten T: Energy balance and body composition in cancer patients. Cancer Res 38: 1801-1807, 1978.
16. Thompson MP, Cooper ST, Parry BR and Tuckey JA: Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients. Biochim Biophys Acta 1180: 236-242, 1993.